Cited by 68Thyroid Disorders and TreatmentsDementia and Cognitive Impairment ResearchMenopause: Health Impacts and Treatments

Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age

Open access
Wijsman, Liselotte W., de Craen, Anton J. M., Trompet, Stella, Gussekloo, Jacobijn, Stott, David J., Rodondi, Nicolas, Welsh, Paul, Jukema, J. Wouter +2 more·2013·PLoS ONE

Abstract

BACKGROUND: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). METHODS: Prospective longitudinal study of men and women aged 70-82 years with pre-existing vascular disease or more than one risk factor to develop this condition (N = 5,154). Participants taking antithyroid medications, thyroid hormone supplementation and/or amiodarone were excluded. Thyroid function was measured at baseline: subclinical hyper- and hypothyroidism were defined as thyroid stimulating hormones (TSH) <0.45 mU/L or >4.50 mU/L respectively, with normal levels of free thyroxine (FT4). Cognitive performance was tested at baseline and at four subsequent time points during a mean follow-up of 3 years, using five neuropsychological performance tests. RESULTS: Subclinical hyperthyroidism and hypothyroidism were found in 65 and 161 participants, respectively. We found no consistent association of subclinical hyper- or hypothyroidism with altered cognitive performance compared to euthyroid participants on the individual cognitive tests. Similarly, there was no association with rate of cognitive decline during follow-up. CONCLUSION: We found no consistent evidence that subclinical hyper- or hypothyroidism contribute to cognitive impairment or decline in old age. Although our data are not in support of treatment of subclinical thyroid dysfunction to prevent cognitive dysfunction in later life, only large randomized controlled trials can provide definitive evidence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0059199

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two recent prospective studies did not find an association between low serum TSH levels and the risk of cognitive impairment and dementia or decreased functional capacity in the elderly.

    “At variance, two recent prospective studies did not find an association between low serum TSH levels and the risk of cognitive impairment and dementia or decreased functional capacity in the elderly [61,62] .”

    From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [61]

    The Discussion reports no association between subclinical thyroid dysfunction and cognitive performance or decline in participants aged 70–82 with vascular disease or risk factors. The Methods define low TSH as subclinical hyperthyroidism, so this supports the cognitive portion of the claim. The study did not report prospective risks of dementia or decreased functional capacity; its functional-capacity scores appear only as baseline characteristics in the Results. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • A large body of literature has investigated possible correlations between SH and cognitive decline.

    “A large body of literature has investigated possible correlations between SH and cognitive decline [reviewed by Gan and Pearce (418), with more recent studies by others (419,420)].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wijsman, L. W., de Craen, A. J. M., Trompet, S., Gussekloo, J., Stott, D. J., Rodondi, N., Welsh, P., Jukema, J. W., Westendorp, R. G. J., & Mooijaart, S. P.
Affiliations
  • Leiden University Medical Center (NL)
  • University of Glasgow (GB)
  • University of Bern (CH)
Corresponding author
Mooijaart, Simon P.
Venue
PLoS ONE
Published
2013-03-12
Volume
8
Issue
3
Pages
e59199
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2073488774
Cited by
68
References
42
Citations by year
2025: 3 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 12 · 2016: 11 · 2015: 10 · 2014: 6 · 2013: 2
FWCI
7.60
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • BORIS (University Library Bern) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Open Access CRIS of the University of Bern
Funders
  • National Science Foundation
  • Bristol-Myers Squibb
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (138267, 320030)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
subclinical hyperthyroidism, subclinical hypothyroidism, subclinical thyroid dysfunction, cognitive decline, cognitive impairment, older adults, thyroid-stimulating hormone, free thyroxine, PROSPER trial, vascular risk
MeSH terms
Aged, Aged, 80 and over, Aging, Cognition Disorders, Female, Humans, Hyperthyroidism, Hypothyroidism, Longitudinal Studies, Male, Neuropsychological Tests, Risk Factors, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review